Product Information
CARBIDOPA-LEVODOPA 10-100 TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.0760 per EA under NDC 72888010601. Its NADAC has been published 169 times since Apr 5, 2023.
Strength
10; 100 mg/1; mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888010601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA216505On Market Since
9/21/2022
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 10-100 TAB has been published 169 times since Apr 5, 2023, and over the history we have for it it has declined 38.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0760 per EA |
|---|---|
| All-time high | $0.1279 (Aug 16, 2023) |
| All-time low | $0.0760 (Jun 17, 2026) |
| 52-week high | $0.0969 |
| 52-week low | $0.0760 |
| Median price | $0.0950 |
| Average price | $0.0978 |
| Largest weekly change | -28.9% (Apr 17, 2024) |
| Weeks tracked | 169 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 10-100 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 10-100 TAB, manufactured by Advagen Pharma Ltd., is $0.0760 per EA (NDC 72888010601), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVODOPA 10-100 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 10-100 TAB has declined 38.8%. It has been tracked across 169 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 10-100 TAB?
Since Apr 5, 2023, the NADAC for CARBIDOPA-LEVODOPA 10-100 TAB has ranged from a low of $0.0760 (Jun 17, 2026) to a high of $0.1279 (Aug 16, 2023), with a median of $0.0950 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 10-100 TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CARBIDOPA-LEVODOPA 10-100 TAB, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVODOPA 10-100 TAB?
CARBIDOPA-LEVODOPA 10-100 TAB (NDC 72888010601) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification